Ran Zhu, Ph.D. - Publications

Bioorganic and Synthetic Organic Chemistry

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhou NN, Zhu R, Zhao XM, Zhang JM, Liang P. [Effect and mechanism of gastrodin inhibiting β-amyloid plaques in brain of mice]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 51: 588-94. PMID 29859528  0.36
2016 Zhou NN, Zhu R, Zhao XM, Liang P. [Effect and mechanism of traditional Chinese herbs against Aβ expression in brain tissues of mice with Alzheimer's disease]. Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology. 45: 780-785. PMID 27821233 DOI: 10.3760/cma.j.issn.0529-5807.2016.11.007  0.36
2016 Chen Y, Lan W, Wang J, Zhu R, Yang Z, Ding D, Tang G, Wang K, Su Q, Xie E. Highly flexible, transparent, conductive and antibacterial films made of spin-coated silver nanowires and a protective ZnO layer Physica E: Low-Dimensional Systems and Nanostructures. 76: 88-94. DOI: 10.1016/j.physe.2015.10.009  0.36
2015 Chen W, Zhu R, Ge C, Lu Y, Li L, Li F, Wu M. [Site-directed mutagenesis of human IL-29 and antineoplastic activity of the recombinant human IL-29 variant]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 31: 702-10. PMID 26571691  0.36
2015 Wang C, Liu L, Zhang Z, Yan Z, Yu C, Shao M, Jiang X, Chi S, Wei K, Zhu R. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin. International Immunopharmacology. PMID 26337750 DOI: 10.1016/j.intimp.2015.08.018  0.36
2015 Li CZ, Zhu R, Ke X, Zhang JM, Wang LX, Zhang L, Liao ZM, Yu DP. Synthesis and Photovoltaic Properties of Cd3As2 Faceted Nanoplates and Nano-Octahedrons Crystal Growth and Design. 15: 3264-3270. DOI: 10.1021/acs.cgd.5b00399  0.36
2015 Li F, Tang G, Wang C, Cui L, Zhu R. Slope spectrum variation in a simulated loess watershed Frontiers of Earth Science. DOI: 10.1007/s11707-015-0519-2  0.36
2014 Zhu R, Huang TX, Zhao XM, Zhang JM, Liang P. [Screening of 10 types of Chinese herbal compounds inhibiting Abeta and their possible related mechanism in vitro]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 49: 800-6. PMID 25212023  0.36
2011 Kennedy PC, Zhu R, Huang T, Tomsig JL, Mathews TP, David M, Peyruchaud O, Macdonald TL, Lynch KR. Characterization of a sphingosine 1-phosphate receptor antagonist prodrug. The Journal of Pharmacology and Experimental Therapeutics. 338: 879-89. PMID 21632869 DOI: 10.1124/jpet.111.181552  1
2011 Zheng J, Su Q, Wang C, Cheng G, Zhu R, Shi J, Yao K. Synthesis and biological evaluation of PMMA/MMT nanocomposite as denture base material. Journal of Materials Science. Materials in Medicine. 22: 1063-71. PMID 21373810 DOI: 10.1007/s10856-011-4269-8  0.36
2008 Sun Q, Zhu R, Foss FW, Macdonald TL. In vitro metabolism of a model cyclopropylamine to reactive intermediate: Insights into trovafloxacin-induced hepatotoxicity Chemical Research in Toxicology. 21: 711-719. PMID 18298092 DOI: 10.1021/tx7003085  1
2007 Zhu R, Snyder AH, Kharel Y, Schaffter L, Sun Q, Kennedy PC, Lynch KR, Macdonald TL. Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist. Journal of Medicinal Chemistry. 50: 6428-35. PMID 17994678 DOI: 10.1021/jm7010172  1
2007 Sun Q, Zhu R, Foss FW, Macdonald TL. Mechanisms of trovafloxacin hepatotoxicity: Studies of a model cyclopropylamine-containing system Bioorganic and Medicinal Chemistry Letters. 17: 6682-6686. PMID 17976985 DOI: 10.1016/j.bmcl.2007.10.070  1
2006 Zhu R, Frazier CR, Linden J, Macdonald TL. N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16: 2416-8. PMID 16487705 DOI: 10.1016/j.bmcl.2006.01.110  1
2005 Kharel Y, Lee S, Snyder AH, Sheasley-O'neill SL, Morris MA, Setiady Y, Zhu R, Zigler MA, Burcin TL, Ley K, Tung KS, Engelhard VH, Macdonald TL, Pearson-White S, Lynch KR. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. The Journal of Biological Chemistry. 280: 36865-72. PMID 16093248 DOI: 10.1074/jbc.M506293200  1
Show low-probability matches.